1. Home
  2. LILA vs OGN Comparison

LILA vs OGN Comparison

Compare LILA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd.

LILA

Liberty Latin America Ltd.

HOLD

Current Price

$7.55

Market Cap

1.5B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.31

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LILA
OGN
Founded
2017
1923
Country
Bermuda
United States
Employees
10000
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LILA
OGN
Price
$7.55
$13.31
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$13.00
$11.40
AVG Volume (30 Days)
222.0K
15.2M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
$7.23
$1.67
P/E Ratio
N/A
$24.26
Revenue Growth
N/A
N/A
52 Week Low
$4.81
$5.69
52 Week High
$9.04
$13.44

Technical Indicators

Market Signals
Indicator
LILA
OGN
Relative Strength Index (RSI) 38.15 77.58
Support Level $7.37 $8.59
Resistance Level $8.24 N/A
Average True Range (ATR) 0.37 0.32
MACD -0.08 0.10
Stochastic Oscillator 31.85 97.87

Price Performance

Historical Comparison
LILA
OGN

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: